FindTrial
Sign In

A study on immunoglobulin behavior in desensitization therapy

A study on immunoglobulin behavior in desensitization therapy - A study on immunoglobulin behavior in desensitization therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044256
Enrollment
40
Registered
2021-05-19
Start date
2021-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis

Interventions

None listed

Sponsors

non-profit organization Japan Health Promotion Support Organization
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have rhinitis symptoms for 2 years or more due to cedar pollen allergy

Exclusion criteria

Exclusion criteria: Patients taking steroids

Design outcomes

Primary

MeasureTime frame
Immunoglobulin levels—

Countries

Japan

Contacts

Public ContactYuki Shiraishi

EPS Holdings, Inc. Souken Center

shiraishi094@eps.co.jp070-3023-8212

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026